A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised tria. Lancet. 2007;370(9583):240-250. Węcławek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, et al. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study. J.Hematol.Oncol. 2021;14(1):163. Elitzur S, Vora A, Burkhardt B, et al. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. Blood. 2023;141(7):743-755. Szczepański T, Van der Velden VHJ, Waanders E, et al. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. J.Clin.Oncol. 2011;29(12):1643-1649. Van Zelm MC, Szczepański T, Van der Burg M, Van Dongen JJM. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J.Exp.Med. 2007;204(3):645-655. Theunissen P, Mejstrikova E, Sędek Ł, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347-357.